Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells. 1989

A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
Institute of Bioorganic Chemistry, Siberian Division of the USSR Academy of Sciences, Novosibirsk.

5'-[32P]-labelled alkylating decathymidylate [4-(N-2-chloroethyl)N-methylaminobenzyl]-5'-phosphamide derivatives containing cholesterol or phenazinium residues at their 3'-termini were synthesized and used for alkylation of DNA within mammalian cells. The uptake of the cholesterol derivative by the cells and the extent of DNA alkylation are about two orders of magnitude higher than those of a similar alkylating derivative lacking the groups at the 3'-termini. The presence of the phenazinium residue at the 3'-terminus of the oligonucleotide reagent does not improve the reagent uptake by the cells but drastically increases the DNA modification efficiency.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D010619 Phenazines
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
January 1989, Molekuliarnaia biologiia,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
March 1992, FEBS letters,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
January 1989, Molekuliarnaia biologiia,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
May 1990, Bioorganicheskaia khimiia,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
January 1997, Molekuliarnaia biologiia,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
January 1991, Mikrobiologicheskii zhurnal,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
May 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
December 2001, Antisense & nucleic acid drug development,
A S Boutorin, and L V Gus'kova, and E M Ivanova, and N D Kobetz, and V F Zarytova, and A S Ryte, and L V Yurchenko, and V V Vlassov
January 1993, Bioorganicheskaia khimiia,
Copied contents to your clipboard!